Protalix BioTherapeutics, Inc.

PLX ·Healthcare, Drug Manufacturers - General, United States

SEC Filings

Form	Filed	Description
8-K	May 14, 2021	8-K
10-K/A	Apr 30, 2021	10-K/A
8-K	Apr 28, 2021	8-K
10-K	Mar 30, 2021	10-K
8-K	Mar 30, 2021	8-K
8-K	Feb 23, 2021	8-K
3	Feb 16, 2021	OWNERSHIP DOCUMENT
SC 13G/A	Feb 16, 2021	SC 13G/A
SC 13G/A	Feb 16, 2021	AMENDMENT NO. 5 TO SCHEDULE 13G
424B5	Feb 16, 2021	424B5
8-K	Feb 16, 2021	FORM 8-K
SC 13G	Feb 12, 2021	SCHEDULE 13G
424B5	Feb 11, 2021	424B5
SC 13G/A	Feb 9, 2021	PROTALIX BIOTHERAPEUTICS, INC.
SC 13G/A	Feb 8, 2021	SC 13G/A
SC 13G/A	Feb 8, 2021	SC 13G
8-K	Dec 30, 2020	8-K
SC 13G	Nov 24, 2020	SC 13G
10-Q	Oct 29, 2020	10-Q
8-K	Oct 29, 2020	8-K
8-K/A	Oct 23, 2020	8-K/A
8-K	Oct 1, 2020	FORM 8-K
424B5	Oct 1, 2020	424B5
8-K	Sep 8, 2020	FORM 8-K
4/A	Aug 14, 2020	FORM 4/A

← Newer Page 9 of 38 · 935 filings Older →